Shares of RTI Surgical Holdings Inc (NASDAQ:RTIX) have been assigned an average rating of “Hold” from the seven ratings firms that are covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell rating and four have assigned a buy rating to the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $6.67.
Several brokerages have recently weighed in on RTIX. Zacks Investment Research lowered shares of RTI Surgical from a “hold” rating to a “sell” rating in a report on Thursday, September 26th. Sidoti began coverage on shares of RTI Surgical in a report on Monday, September 16th. They set a “buy” rating and a $5.00 price objective on the stock. Finally, ValuEngine lowered shares of RTI Surgical from a “hold” rating to a “sell” rating in a report on Monday, September 30th.
Hedge funds and other institutional investors have recently made changes to their positions in the company. Meeder Asset Management Inc. raised its holdings in shares of RTI Surgical by 78.7% in the 2nd quarter. Meeder Asset Management Inc. now owns 10,505 shares of the medical equipment provider’s stock worth $45,000 after acquiring an additional 4,627 shares during the last quarter. Jane Street Group LLC acquired a new stake in shares of RTI Surgical in the 2nd quarter worth about $65,000. BNP Paribas Arbitrage SA raised its holdings in shares of RTI Surgical by 686.8% in the 1st quarter. BNP Paribas Arbitrage SA now owns 11,771 shares of the medical equipment provider’s stock worth $71,000 after acquiring an additional 10,275 shares during the last quarter. Marshall Wace North America L.P. acquired a new stake in shares of RTI Surgical in the 1st quarter worth about $79,000. Finally, Connor Clark & Lunn Investment Management Ltd. raised its holdings in shares of RTI Surgical by 62.0% in the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 25,615 shares of the medical equipment provider’s stock worth $109,000 after acquiring an additional 9,800 shares during the last quarter. Hedge funds and other institutional investors own 58.79% of the company’s stock.
RTI Surgical (NASDAQ:RTIX) last announced its quarterly earnings data on Thursday, August 1st. The medical equipment provider reported $0.01 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.02. RTI Surgical had a negative net margin of 1.08% and a positive return on equity of 3.55%. The firm had revenue of $82.31 million for the quarter. Analysts expect that RTI Surgical will post 0.02 EPS for the current fiscal year.
About RTI Surgical
RTI Surgical Holdings, Inc, a surgical implant company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes.
Featured Story: How to find the components of the quick ratio
Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.